Sarissa Capital Management LP Amarin Corp Plcuk Transaction History
Sarissa Capital Management LP
- $323 Million
- Q4 2024
A detailed history of Sarissa Capital Management LP transactions in Amarin Corp Plcuk stock. As of the latest transaction made, Sarissa Capital Management LP holds 24,850,623 shares of AMRN stock, worth $257 Million. This represents 3.7% of its overall portfolio holdings.
Number of Shares
24,850,623
Previous 24,850,623
-0.0%
Holding current value
$257 Million
Previous $15.7 Million
23.81%
% of portfolio
3.7%
Previous 3.89%
Shares
8 transactions
Others Institutions Holding AMRN
# of Institutions
175Shares Held
71MCall Options Held
183KPut Options Held
66.7K-
Kynam Capital Management, LP Princeton, NJ12.4MShares$128 Million0.38% of portfolio
-
Morgan Stanley New York, NY4.41MShares$45.5 Million0.0% of portfolio
-
Waterfront Wealth Inc.2.51MShares$26 Million5.52% of portfolio
-
Scp Investment, LP2.5MShares$25.8 Million1.0% of portfolio
-
Two Sigma Investments, LP New York, NY2.17MShares$22.5 Million0.0% of portfolio
About AMARIN CORP PLCUK
- Ticker AMRN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 403,206,016
- Market Cap $4.17B
- Description
- Amarin Corporation plc, a pharmaceutical company, engages in the development and commercialization of therapeutics for the treatment of cardiovascular diseases in the United States, Germany, Canada, Lebanon, and the United Arab Emirates. Its lead product is VASCEPA, a prescription-only omega-3 fatty acid product, used as an adjunct to diet for r...